163 related articles for article (PubMed ID: 30221728)
1. Combination of pristimerin and paclitaxel additively induces autophagy in human breast cancer cells via ERK1/2 regulation.
Lee Y; Na J; Lee MS; Cha EY; Sul JY; Park JB; Lee JS
Mol Med Rep; 2018 Nov; 18(5):4281-4288. PubMed ID: 30221728
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
3. Anticancer activity of pristimerin in epidermal growth factor receptor 2-positive SKBR3 human breast cancer cells.
Lee JS; Yoon IS; Lee MS; Cha EY; Thuong PT; Diep TT; Kim JR
Biol Pharm Bull; 2013; 36(2):316-25. PubMed ID: 23370361
[TBL] [Abstract][Full Text] [Related]
4. Pristimerin Induces Autophagy-Mediated Cell Death in K562 Cells through the ROS/JNK Signaling Pathway.
Liu Y; Ren Z; Li X; Zhong J; Bi Y; Li R; Zhao Q; Yu X
Chem Biodivers; 2019 Aug; 16(8):e1900325. PubMed ID: 31290253
[TBL] [Abstract][Full Text] [Related]
5. A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer.
Cevatemre B; Erkısa M; Aztopal N; Karakas D; Alper P; Tsimplouli C; Sereti E; Dimas K; Armutak EII; Gurevin EG; Uvez A; Mori M; Berardozzi S; Ingallina C; D'Acquarica I; Botta B; Ozpolat B; Ulukaya E
Pharmacol Res; 2018 Mar; 129():500-514. PubMed ID: 29197639
[TBL] [Abstract][Full Text] [Related]
6. Molecular imaging of the kinetics of hyperactivated ERK1/2-mediated autophagy during acquirement of chemoresistance.
Bishnu A; Phadte P; Dhadve A; Sakpal A; Rekhi B; Ray P
Cell Death Dis; 2021 Feb; 12(2):161. PubMed ID: 33558461
[TBL] [Abstract][Full Text] [Related]
7. Cucurbitacin I induces pro-death autophagy in A549 cells via the ERK-mTOR-STAT3 signaling pathway.
Ni Y; Wu S; Wang X; Zhu G; Chen X; Ding Y; Jiang W
J Cell Biochem; 2018 Jul; 119(7):6104-6112. PubMed ID: 29575175
[TBL] [Abstract][Full Text] [Related]
8. Pineapple bromelain induces autophagy, facilitating apoptotic response in mammary carcinoma cells.
Bhui K; Tyagi S; Prakash B; Shukla Y
Biofactors; 2010; 36(6):474-82. PubMed ID: 20848558
[TBL] [Abstract][Full Text] [Related]
9. Pristimerin demonstrates anticancer potential in colorectal cancer cells by inducing G1 phase arrest and apoptosis and suppressing various pro-survival signaling proteins.
Yousef BA; Guerram M; Hassan HM; Hamdi AM; Zhang LY; Jiang ZZ
Oncol Rep; 2016 Feb; 35(2):1091-100. PubMed ID: 26718323
[TBL] [Abstract][Full Text] [Related]
10. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S
J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691
[TBL] [Abstract][Full Text] [Related]
11. A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.
Menendez JA; Vellon L; Mehmi I; Teng PK; Griggs DW; Lupu R
Oncogene; 2005 Jan; 24(5):761-79. PubMed ID: 15592521
[TBL] [Abstract][Full Text] [Related]
12. Pristimerin induces apoptosis and autophagy via activation of ROS/ASK1/JNK pathway in human breast cancer in vitro and in vivo.
Zhao Q; Liu Y; Zhong J; Bi Y; Liu Y; Ren Z; Li X; Jia J; Yu M; Yu X
Cell Death Discov; 2019; 5():125. PubMed ID: 31396402
[TBL] [Abstract][Full Text] [Related]
13. The mTOR inhibition in concurrence with ERK1/2 activation is involved in excessive autophagy induced by glycyrrhizin in hepatocellular carcinoma.
Zhang X; Yang H; Yue S; He G; Qu S; Zhang Z; Ma B; Ding R; Peng W; Zhang H; Yang Z; Dou K; Tao K; Li X
Cancer Med; 2017 Aug; 6(8):1941-1951. PubMed ID: 28675698
[TBL] [Abstract][Full Text] [Related]
14. A Hopeful Natural Product, Pristimerin, Induces Apoptosis, Cell Cycle Arrest, and Autophagy in Esophageal Cancer Cells.
Huang P; Sun LY; Zhang YQ
Anal Cell Pathol (Amst); 2019; 2019():6127169. PubMed ID: 31218209
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ERα/ERK/P62 cascades induces "autophagic switch" in the estrogen receptor-positive breast cancer cells exposed to gemcitabine.
Shen P; Chen M; He M; Chen L; Song Y; Xiao P; Wan X; Dai F; Pan T; Wang Q
Oncotarget; 2016 Jul; 7(30):48501-48516. PubMed ID: 27384485
[TBL] [Abstract][Full Text] [Related]
16. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
17. Deltonin induces apoptosis in MDA‑MB‑231 human breast cancer cells via reactive oxygen species‑mediated mitochondrial dysfunction and ERK/AKT signaling pathways.
Zhang S; He Y; Tong Q; Chen Q; Wu X; Huang W
Mol Med Rep; 2013 Mar; 7(3):1038-44. PubMed ID: 23314115
[TBL] [Abstract][Full Text] [Related]
18. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
19. Autophagy induction by capsaicin in malignant human breast cells is modulated by p38 and extracellular signal-regulated mitogen-activated protein kinases and retards cell death by suppressing endoplasmic reticulum stress-mediated apoptosis.
Choi CH; Jung YK; Oh SH
Mol Pharmacol; 2010 Jul; 78(1):114-25. PubMed ID: 20371669
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
Wu W; Pew T; Zou M; Pang D; Conzen SD
J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
